Path to Improved Risk Stratification
Path to Improved Risk Stratification
批准号:
9125490
负责人:
JEFFREY J GOLDBERGER
金额:
$1.2万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2017-03-31
关键词:
AddressAreaAttentionBostonCessation of lifeChicagoClinicalClinical TrialsCollaborationsCommunicationDevelopmentDistrict of ColumbiaEconomicsEpidemiologyEthicsEventFosteringGoalsGovernment AgenciesHealth Care ResearchHealthcareHeart ArrestHospitalsIndividualIndustryInstitutesInsuranceInvestmentsKnowledgeMinorityMissionNational Heart, Lung, and Blood InstituteParticipantPatientsPhysiciansPreventionPrevention strategyProfessional OrganizationsPublic HealthReportingResearchResearch PersonnelResuscitationRiskSaint Jude Children&aposs Research HospitalScientistStratificationTechniquesTeleconferencesTestingThinkingTimeUnited StatesUnited States Agency for Healthcare Research and QualityUnited States Centers for Medicare and Medicaid ServicesUnited States Food and Drug AdministrationUpdateWashingtonWomanWorkbasedesignexperiencehealth care qualityhealth economicsheuristicsimprovedinnovationinterestknowledge basemeetingsmembersoundsuccesssudden cardiac deathsymposiumtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Sudden cardiac death is a major public health problem with approximately 180,000 to 400,000 deaths annually. Because of the low efficacy and success rates of out-of-hospital resuscitation, a high priority has been set to try and identif individuals at risk for sudden cardiac death prior to the event. If this can be done, there are treatments that can be instituted to mitigate this risk. However, despite decades of research, and significant investments of time, effort, and research dollars, there is not yet an ideal or eve acceptable approach to risk stratification for sudden cardiac death. One approach that could be initiated to engender more rapid progress in this area is to promote better coordination among the various stakeholders - investigators, government agencies, and industry. Although all are vested in the need for risk stratification, each group has different sets of priorities and therefoe approaches the problem from different perspectives. The Path to Improved Risk Stratification, NFP is a not-for-profit think tank founded by Dr. Jeffrey Goldberger whose mission is to serve as a focal point to help organize a rational, coordinated plan for developing, evaluating, and implementing risk stratification strategies for prevention of sudden cardiac death. The Path to Improved Risk Stratification, NFP has organized annual single day meetings in Chicago from 2005-2012 and in Washington in 2014 and 2015 with: 1) physician leaders in the area of risk stratification, clinical trials in prevention of sudden cardiac death, epidemiology, and health economics; 2) representatives from the relevant government agencies; 3) representatives from industry. The meeting agendas are designed to identify important gaps in our knowledge and to strategize how those gaps can best be filled. These meetings have resulted in new efforts in risk stratification and have helped guide some clinical trials that have been in development. The agenda for each meeting is to evaluate progress from the prior meeting, review new information relevant to risk stratification, discuss issues related to ongoing clinical trials, obtain updates n planning of new trials, review scientific/statistical/economics issues related to risk stratificatin, and explore new areas that are gaps in our knowledge base. Having identified the gaps, there is now greater emphasis on developing an action plan to address some of the identified gaps. Given the vastness of the information that needs to be understood to advance the field of risk stratification, this effort provides an important sounding board for those involved and encourages collaboration and the development of innovative approaches.
Narrative: The Path to Improved Risk Stratification for Sudden Cardiac Death conference is a think tank of multiple stakeholders interested in improving our ability to identify patients at ris for sudden cardiac death prior to suffering this event. As this is a major public health problem, leading to approximately 180000 to 400000 deaths annually, a collaborative effort is necessary to overcome the barriers to advancement in this field.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1161/circulationaha.116.027134
发表时间:
2017-07-11
期刊:
Circulation
影响因子:
37.8
作者:
[Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK]
通讯作者:
Prasad SK
Pathophysiological Significance of Atrial Fibrillation Electrogram Patterns
-
批准号:10634983
-
项目类别:
-
资助金额:$70.38万
-
财政年份:2023
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
-
批准号:10330560
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2021
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
-
批准号:10553649
-
项目类别:
-
资助金额:$69.08万
-
财政年份:2021
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
-
批准号:10096986
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2021
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
Novel medical adjunctive therapy to catheter ablation for atrial fibrillation
-
批准号:10113417
-
项目类别:
-
资助金额:$71.99万
-
财政年份:2019
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
Path to Improved Risk Stratification
-
批准号:8719852
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2014
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
4D Magnetic Resonance Imaging for Atrial Flow Assessment in Atrial Fibrillation
-
批准号:8605912
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2013
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
4D Magnetic Resonance Imaging for Atrial Flow Assessment in Atrial Fibrillation
-
批准号:8445112
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2013
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PHYSIOLOGY OF HEART RATE RECOVERY AFTER SUBMAXIMAL EXERCISE IN SUBJECTS WITH CAD
-
批准号:7604258
-
项目类别:
-
资助金额:$6.03万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
INFARCT CHARACTERISTICS DETERMINED BY CARDIAC MRI PREDICTIVE OF ARRHYTHMIC EVENT
-
批准号:7604307
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PACEmaker & Beta-Blocker Therapy Post-Myocardial Infarct
-
批准号:7018363
-
项目类别:
-
资助金额:$130.0万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PACEmaker & Beta-Blocker Therapy Post-Myocardial Infarct
-
批准号:7494973
-
项目类别:
-
资助金额:$81.06万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PACEmaker & Beta-Blocker Therapy Post-Myocardial Infarct
-
批准号:7295957
-
项目类别:
-
资助金额:$312.42万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PACEmaker & Beta-Blocker Therapy Post-Myocardial Infarct
-
批准号:7689472
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PACEmaker & Beta-Blocker Therapy Post-Myocardial Infarct
-
批准号:8400381
-
项目类别:
-
资助金额:$59.01万
-
财政年份:2006
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PHYSIOLOGY OF HEART RATE RECOVERY AFTER SUBMAXIMAL EXERCISE IN SUBJECTS WITH CAD
-
批准号:7376850
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2005
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
CARDIAC MEMORY AND DIASTOLIC FUNCTION
-
批准号:7376819
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2005
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
CARDIAC MRI PREDICTORS IN A "MADIT-II-LIKE" POPULATION
-
批准号:7376910
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2005
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
PHYSIOLOGY OF HEART RATE RECOVERY AFTER SUBMAXIMAL EXERCISE IN SUBJECTS WITH CAD
-
批准号:7200455
-
项目类别:
-
资助金额:$1.24万
-
财政年份:2004
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
WHAT IS BRADYCARDIA IN PATIENTS WITH CONGESTIVE HEART FAILURE?
-
批准号:7200476
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2004
-
负责人:JEFFREY J GOLDBERGER
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: